Research Analysts Issue Forecasts for Mirum Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:MIRM)

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Rating) – SVB Leerink issued their FY2025 earnings per share estimates for Mirum Pharmaceuticals in a research note issued to investors on Thursday, May 4th. SVB Leerink analyst M. Foroohar anticipates that the company will post earnings per share of $1.93 for the year. SVB Leerink has a “Outperform” […]

Related Keywords

Niall Odonnel ,Raymond James ,Christopher Peetz ,Mirum Pharmaceuticals Company Profile ,Raymond James Associates ,Securities Exchange Commission ,Sg Americas Securities ,Mirum Pharmaceuticals Inc ,Insider Transactions At Mirum Pharmaceuticals ,Mirae Asset Global Investments Co ,Mirum Pharmaceuticals Stock Performance ,Nasdaq ,Columbus Asset Advisors ,News Ratings For Mirum Pharmaceuticals Daily ,Hermes Inc ,Mirum Pharmaceuticals ,Get Rating ,Mirum Pharmaceutical ,Asset Global Investments ,Director Michael ,Exchange Commission ,Niallo Donnel ,Michael Grey ,Foster City ,Mirum Pharmaceuticals Daily ,Nasdaq Mirm ,Smirm ,Medical ,Earnings Estimates ,Svb Leerink Llc ,